Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Wandtke (Bydgoszcz, Poland), P. Kopinski (Krakow, Poland), G. Przybylski (Bydgoszcz, Poland), E. Wedrowska (Bydgoszcz, Poland), M. Gnass (Krakow, Poland), J. Golinska (Bydgoszcz, Poland), K. Szablowska (Bydgoszcz, Poland), J. Chorostowska-Wynimko (Warsaw, Poland). Active clinical pulmonary sarcoidosis is characterized by significantly reduced apoptosis rate of alveolar lymphocytes (AL). 4393

Member's Comments

No comment yet.

Related content which might interest you: Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Massive apoptosis of alveolar lymphocytes (AL) in the course of pulmonary sarcoidosis (PS) as a predictor of disease remission Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005 Differences in alveolar cell populations, natural killer cells and lymphocyte subsets between pulmonary sarcoidosis (PS) and idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Enhanced apoptosis of alveolar lymphocytes (AL), but not macrophages (AM) in interstitial idiopathic pneumonias (IIPs). Special attention to idiopathic pulmonary fibrosis (IPF) results Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Extensive alveoalar lymphocyte apoptosis in pulmonary sarcoidosis (PS) followed by clinical improvement. Two distinct apoptosis presentations? Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004 Elevated apoptosis rate of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonitis (NSIP) – strong positive correlation with bronchoalvoelar lavage (BAL) neutrophil count. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Decreased BCL-2 expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Effect of cigarette smoking on alveolar macrophages (AM) and lymphocytes (AL) apoptosis in selected interstitial lung diseases (ILD) Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 Decreased mitochondrial complex I activity in blood lymphocytes of patients with idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 Decreased apoptotic rate of alveolar macrophages of patients with idiopathic pulmonary fibrosis is not associated with difference in expression of fas or fas ligand Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Activated lymphoid follicles, sign of an immune response, are present in early idiopathic pulmonary fibrosis (IPF) and increase with disease progression. Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 M2 polarized alveolar macrophages in pulmonary fibrosis Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Antigen presenting cells of lower airways in interstitial lung diseases (ILD). Do alveolar lymphocytes possess the ability to present antigens? Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD Source: Eur Respir J 2004; 23: 532-537 Year: 2004 The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Clinical and functional features in idiopathic pulmonary fibrosis (IPF) with and without haemosiderin-laden alveolar macrophages on BALF Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011 Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001